Review of the scientific literature on drivers and barriers of seasonal influenza vaccination coverage in the EU/EEA
The report aims to provide a critical review of evidence on the barriers and drivers of seasonal influenza vaccination coverage in the EU/EEA. The report focuses on high-risk groups where high coverage of seasonal flu vaccination is most important. The 2009 Council of the European Union Recommendation on seasonal influenza vaccination encourages countries to implement measures that would increase seasonal influenza vaccination uptake to at least 75% for defined older age groups, and, if possible, for other risk groups. In support of this, the ECDC report summarises the evidence on what are the barriers and what are the drivers for seasonal influenza vaccination by each risk group
Expert opinion on priority risk groups for influenza vaccination
This paper identifies and describes population groups at increased risk for severe outcomes of influenza (“risk groups”) and advocates vaccination for two major groups, namely a) persons in the older age group, usually 65 years and older; and b) persons with chronic medical conditions.
Interim technical guidance on public health use of influenza antivirals during influenza pandemics
Antiviral drugs are an important addition to the public health arsenal against influenza. This interim guidance discusses the options for their effective use, especially during a pandemic.
Interim technical guidance on use of specific pandemic influenza vaccines during the H1N1 2009 pandemic
This interim guidance outlines the possible strategies that countries may wish to adopt in the deployment of a pandemic-specific vaccine, considering the two objectives of vaccination: protecting those at greatest risk of severe disease and maintaining essential services.
Questions and answers about antivirals
Frequently asked questions about the use of antivirals for prevention and treatment of influenza; What are the uses of antivirals against seasonal influenza? Which are the antivirals we use in Europe against seasonal influenza and who should get them? If antivirals are so good why don’t doctors give them out more often? Do people who have been immunized against influenza need antivirals?
Factsheet about seasonal influenza
Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and sometimes the lungs. It can cause mild to severe illness, and at times can lead to death. The best way to prevent flu is by getting a flu vaccine each year.
Flu transmits easily from person to person. It does this through the air or from contaminated hands or surfaces. The risk of getting or causing infection is easily reduced by taking some simple preventive steps. Immunisation in particular decreases the risk of a person being infected. Proper use of flu vaccines is the most effective form of protection.
Types of seasonal influenza vaccine
Injected trivalent inactivated influenza vaccines are most commonly used throughout the world. Influenza antigen preparation varies between manufacturers. The inactivated influenza vaccines available in the EU/EEA may contain either split virion influenza virus products or subunit influenza products.
PRECEPT: An evidence assessment framework for infectious disease epidemiology, prevention and control
Harder, T., Takla, A., Eckmanns, T., Ellis, S., Forland, F., James, R., Meerpohl, J.J., Morgan, A., Rehfuess, E., Schünemann, H., Zuiderent-Jerak, T., De Carvalho Gomes, H., Wichmann, O.
Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: A protocol for a suite of systematic reviews for public health and health systems
Pottie, K., Mayhew, A.D., Morton, R.L., Greenaway, C., Akl, E.A., Rahman, P., Zenner, D., Pareek, M., Tugwell, P., Welch, V., Meerpohl, J., Alonso-Coello, P., Hui, C., Biggs, B.-A., Requena-Méndez, A., Agbata, E., Noori, T., Schünemann, H.J.